Skip to main content
SpringerLink
Log in

Standards der Diagnostik und Therapie des Magenkarzinoms

Standards for diagnostics and therapy of gastric cancer

  • CME Zertifizierte Fortbildung
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Das Magenkarzinom ist, trotz abnehmender Häufigkeit, die fünft- bzw. sechsthäufigste Krebsart in Deutschland. Zumeist werden die Karzinome erst in einem fortgeschrittenen Stadium entdeckt. Dieser Beitrag orientiert sich hauptsächlich an der aktuellen S3-Leitlinie von 2011. Abgehandelt werden sollen allgemeine Aspekte zu Risikofaktoren, zur Diagnostik mit der aktuellen Klassifikationen sowie zur Therapie. Gerade in den letzten Jahren haben sich viele Studien mit dem perioperativen Konzept beschäftigt. Damit haben sich auch Neuerungen ergeben. Ein weltweiter Therapiestandard konnte jedoch für diese Indikation noch nicht etabliert werden.

Abstract

Despite a decreasing frequency gastric cancer is the fifth or sixth most common cancer in Germany. Usually the cancer is discovered in an advanced stage. This article is based primarily on the current S3 guidelines for gastric cancer published 2011. General aspects of risk factors, diagnosis and therapy with the current classification system are the main topics in this article. Furthermore, this article focuses on treatment of local advanced disease. Especially in recent years, many studies have dealt with the concept of perioperative treatment. However, a worldwide standard of care could not be reached for this indication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. The EUROGAST Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:1359

    Article  Google Scholar 

  2. Kamada T, Kurose H, Yamanka Y et al (2012) Relationship between gastroesophageal junction adenocarcinoma and Helicobacter pylori infection in Japan. Digestion 85:256–260

    Article  PubMed  Google Scholar 

  3. Uemura N, Okamoto S, Yamamoto S et al (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789

  4. Namikawa T, Hanazaki K (2010) Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma. World J Gastroenterol 16:4634–4639

    Article  PubMed Central  PubMed  Google Scholar 

  5. Ohnishi N, Yuasa H, Tanaka S et al (2008) Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A 105:1003

    Article  Google Scholar 

  6. Figueiredo C, Machado JC, Pharoah P et al (2002) Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94:1680–1687

  7. Malfertheiner P, Megraud F, O’Morain CA et al (2012) Management of Helicobacter pylori infection—the Maastricht IV/Florence Consensus Report. Gut 61:646–664

    Article  CAS  PubMed  Google Scholar 

  8. Tsugane S, Tei Y, Takahashi T et al (1994) Salty food intake and risk of Helicobacter pylori infection. Jpn J Cancer Res 85:474–478

    Article  CAS  PubMed  Google Scholar 

  9. You WC, Brown LM, Zhang L et al (2006) Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 98:974–983

  10. Fukase K, Kato M, Kikuchi S et al (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372:392–397

    Article  PubMed  Google Scholar 

  11. Shin CM, Kim N, Yang HJ et al (2010) Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol 44:e34–e39

  12. Oliveira C, Senz J, Kaurah P et al (2009) Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 18:1545–1555

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Blair V, Martin I, Shaw D et al (2006) Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol 4:262–275

    Article  CAS  PubMed  Google Scholar 

  14. Cisco RM, Ford JM, Norton JA (2008) Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer 113(7 Suppl):1850–1856

    Article  CAS  PubMed  Google Scholar 

  15. Suriano G, Yew S, Ferreira P et al (2005) Characterization of a recurrent germline mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 11:5401–5409

    Article  CAS  PubMed  Google Scholar 

  16. Koornstra JJ, Mourits MJ, Sijmons RH et al (2009) Management of extracolonic tumours in patients with Lynch syndrome. Lancet Oncol 10:400–408

    Article  CAS  PubMed  Google Scholar 

  17. Capelle LG, Van Grieken NC, Lingsma HF et al (2010) Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 138:487–492

    Article  PubMed  Google Scholar 

  18. Park YJ, Shin KH, Park JG (2000) Risk of gastric cancer in hereditary nonpoly- posis colorectal cancer in Korea. Clin Cancer Res 6(8):2994–2998

    CAS  PubMed  Google Scholar 

  19. Geary J, Sasieni P, Houlston R et al (2008) Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer 7:163–172

    Article  CAS  PubMed  Google Scholar 

  20. Schulmann K, Brasch FE, Kunstmann E et al (2005) HNPCC-associated small bowel cancer: clinical and molecular characteristics. Gastroenterology 128:590–599

    Article  CAS  PubMed  Google Scholar 

  21. UICC (o J) Neue TNM-Klassifikation, 7. Aufl. http://www.uicc.org

  22. Graham DY, Schwartz JT, Cain GD, Gyorkey F (1982) Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology 82:228

    CAS  PubMed  Google Scholar 

  23. Moehler M et al (2011) S3-Leitlinie Magenkarzinom. Z Gastroenterol 49:461–531

  24. Gines A, Pellise M, Fernandez-Esparrach G et al (2006) Endoscopic ultrasonography in patients with large gastric folds at endoscopy and biopsies negative for malignancy: predictors of malignant disease and clinical impact. Am J Gastroenterol 101:64–69

    Article  PubMed  Google Scholar 

  25. Kinkel K, Lu Y, Both M et al (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224:748–756

    Article  PubMed  Google Scholar 

  26. Strobel D, Seitz K, Blank W et al (2009) Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med 30:376–382

    Article  CAS  PubMed  Google Scholar 

  27. Overhagen H van, Lameris JS, Berger MY et al (1992) Assessment of distant metastases with ultrasound-guided fine-needle aspiration biopsy and cytologic study in carcinoma of the esophagus and gastroesophageal junction. Gastrointest Radiol 17:305–310

    Article  PubMed  Google Scholar 

  28. Kwee RM, Kwee TC (2007) Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 25:2107–2116

  29. Oldenburg A, Albrecht T (2008) Baseline and contrast-enhanced ultrasound of the liver in tumor patients. Ultraschall Med 29:488–498

    Article  CAS  PubMed  Google Scholar 

  30. Hori Y, SAGES Guidelines Committee (2008) Diagnostic laparoscopy guidelines. Surg Endosc 22:1353–1383

    Article  PubMed  Google Scholar 

  31. Shiraishi N, Sato K, Yasuda K et al (2007) Multivariate prognostic study on large gastric cancer. J Surg Oncol 96:14–18

  32. Gravalos C, Jimeno A (2008) HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 19:1523–1529

    Article  CAS  PubMed  Google Scholar 

  33. Tanner M, Hollmén M, Junttila TT et al (2005) Amplification of HER-2 in gastric carcinoma: association with topoisomerase II alpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol 16:273–278

    Article  CAS  PubMed  Google Scholar 

  34. Maresch J, Schoppmann SF, Thallinger CM et al (2011) Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment. Crit Rev Oncol Hematol 82:310–322

    Article  PubMed  Google Scholar 

  35. Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697

    Article  CAS  PubMed  Google Scholar 

  36. Hölscher A, Drebber U, Mönig S et al (2009) Early gastric cancer – lymph node metastasis starts with deep mucosal infiltration. Ann Surg 250:791–797

    Article  PubMed  Google Scholar 

  37. Tani M, Sakai P, Kondo H (2003) Endoscopic mucosal resection of superficial cancer in the stomach using the cap technique. Endoscopy 35:348–355

    Article  CAS  PubMed  Google Scholar 

  38. Gotoda T (2007) Endoscopic resection of early gastric cancer. Gastric Cancer 10:1–11

    Article  PubMed  Google Scholar 

  39. Watanabe K, Ogata S, Kawazoe S et al (2006) Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc 63:776–782

    Article  PubMed  Google Scholar 

  40. Song KY, Park SM, Kim SN et al (2008) The role of surgery in the treatment of recurrent gastric cancer. Am J Surg 196:19–22

    Article  PubMed  Google Scholar 

  41. Allum WH, Stenning SP, Bancewicz J et al (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27:5062–5067

  42. Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234

    Article  CAS  PubMed  Google Scholar 

  43. MacDonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730

  44. Kim S, Lim DH, Lee J et al (2005) An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys 63:1279–1285

    Article  PubMed  Google Scholar 

  45. Lee J, Lim DH, Kim S et al (2012) Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol 30:268–273

  46. Bajetta E (2012) Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) trial: comparison of a sequential treatment with irinotecan (CPT-11) plus 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer. J Clin Oncol (Suppl): Abstract LBA4001

  47. Chong G, Cunningham D (2005) Can cisplatin and infused 5-fluorouracil be replaced by oxaliplatin and capecitabine in the treatment of advanced oesophagogastric cancer? The REAL 2 trial. Clin Oncol (R Coll Radiol) 17:79–80

    Google Scholar 

  48. Van Cutsem E, Moiseyenko VM, Tjulandin S et al (2006) Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 24:4991–4997

  49. Yonemura Y, Aretxabala X de, Fujimura T et al (2001) Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology 48:1776–1782

    CAS  PubMed  Google Scholar 

  50. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374

    Article  CAS  PubMed  Google Scholar 

  51. Thelen A, Jonas S, Benckert C et al (2008) Liver resection for metastatic gastric cancer. Eur J Surg Oncol 34:1328–1334

    Article  CAS  PubMed  Google Scholar 

  52. Grundmann RT, Hölscher AH, Bembenek A et al (2009) Diagnosis of and therapy for gastric cancer – work-flow. Zentralbl Chir 134:362–374

    Article  CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. N. Schulte und M. Ebert geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. II. Medizinische Klinik, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1–3, 68167, Mannheim, Deutschland

    N. Schulte & M. Ebert

Authors
  1. N. Schulte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Ebert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Schulte.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schulte, N., Ebert, M. Standards der Diagnostik und Therapie des Magenkarzinoms. Internist 55, 925–941 (2014). https://doi.org/10.1007/s00108-013-3381-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-013-3381-x

Schlüsselwörter

Keywords

Search

Navigation